Alkermes (NASDAQ:ALKS) reported Q4 EPS of $0.14, $0.09 better than the analyst estimate of $0.05. Revenue for the quarter came in at $304.67 million versus the consensus estimate of $290.74 million.
Alkermes (NASDAQ:ALKS) reported Q4 EPS of $0.14, $0.09 better than the analyst estimate of $0.05. Revenue for the quarter came in at $304.67 million versus the consensus estimate of $290.74 million.